The estimated Net Worth of Jacqueline Studer is at least $3.35 Million dollars as of 25 February 2019. Jacqueline Studer owns over 2,529 units of Idexx Laboratories stock worth over $2,151,751 and over the last 13 years Jacqueline sold IDXX stock worth over $1,199,339.
Jacqueline has made over 17 trades of the Idexx Laboratories stock since 2015, according to the Form 4 filled with the SEC. Most recently Jacqueline sold 2,529 units of IDXX stock worth $532,532 on 25 February 2019.
The largest trade Jacqueline's ever made was exercising 11,619 units of Idexx Laboratories stock on 21 August 2018 worth over $951,945. On average, Jacqueline trades about 2,186 units every 55 days since 2011. As of 25 February 2019 Jacqueline still owns at least 4,389 units of Idexx Laboratories stock.
You can see the complete history of Jacqueline Studer stock trades at the bottom of the page.
Jacqueline's mailing address filed with the SEC is 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO, IL, 60654.
Over the last 21 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers, and Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
Idexx Laboratories executives and other stock owners filed with the SEC include: